Gilead Sciences has commenced 2026 with a demonstrably strong first quarter, reporting significant revenue growth primarily fueled by its leading…
Read More
GSK Secures Promising Metabolic Oligonucleotide Therapy Rights from SiranBio in Up to $1 Billion Deal
In a significant move to bolster its pipeline and solidify its strategic focus on the complex challenges of obesity, global…
Read More
The Shifting Landscape of Gene Therapy: Non-Viral Approaches Emerge as Promising Alternatives
Cell and gene therapies (CGTs) have long been heralded for their potential to revolutionize the treatment of complex and previously…
Read More
Researchers at the University of Nebraska–Lincoln Develop Promising New Vaccine Against Bird Flu
A groundbreaking vaccine platform, meticulously engineered to provide robust protection against multiple strains of highly pathogenic avian influenza (HPAI) H5N1,…
Read More
Tavapadon Poised for Competitive Parkinson’s Disease Market Following Promising Tremor Data
AbbVie’s tavapadon, an investigational oral once-daily dopamine D1/D5 partial agonist, is nearing a potential regulatory submission, bolstered by new post-hoc…
Read More
Groundbreaking Nanodisc Platform Unveils Unprecedented Insights into Viral Protein-Antibody Interactions, Promising Accelerated Vaccine Development
A pioneering scientific breakthrough has emerged from Scripps Research in California, USA, in collaboration with IAVI (New York, USA) and…
Read More
Implantable "Living Pharmacy" Produces Multiple Drugs Inside the Body, Promising a New Era for Chronic Disease Management
A groundbreaking device, dubbed a "living pharmacy," capable of producing multiple therapeutic agents simultaneously within the body, has demonstrated significant…
Read More
Sanofi Secures Global Rights to Kali Therapeutics’ Promising Tri-Specific Antibody KT501 for Autoimmune Diseases in a Landmark $1.23 Billion Deal
Sanofi has entered into an exclusive global license agreement with Kali Therapeutics, a significant move that grants the pharmaceutical giant…
Read More
Novartis Acquires Promising Breast Cancer Drug SNV4818 from Synnovation Therapeutics for Up to $3 Billion
Novartis has announced a significant strategic move to bolster its oncology pipeline with the acquisition of SNV4818, an investigational oral…
Read More
Breakthrough Research Uncovers Blood Metabolite Signatures for Earlier Gallbladder Cancer Detection, Promising Non-Invasive Diagnostics
A groundbreaking collaborative effort between researchers at Tezpur University in India and the University of Illinois Urbana-Champaign has successfully identified…
Read MoreYOU MAY HAVE MISSED
